Bristol-Myers Squibb Co

BMY

Equity

ISIN null / Valor 914188

New York Stock Exchange, Inc (2025-11-14)

USD 46.65-4.07%

Bristol-Myers Squibb Co
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

Bristol-Myers Squibb Co is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines to help patients overcome serious diseases. With a mission to improve patient outcomes, the company is dedicated to advancing medical research and developing cutting-edge treatments in various therapeutic areas. As a leading player in the pharmaceutical industry, Bristol-Myers Squibb Co is committed to making a positive impact on the lives of patients worldwide through its innovative drug development and delivery.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.3%1Y

-38.9%3Y

-26.7%5Y

Performance

28.5%1Y

25.6%3Y

23.4%5Y

Volatility

94968 M

Market cap (USD)

19,779,277

Daily traded volume (Shares)

57.55 / 56.05

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

4.00

Nature:

4.00

Nojus Okleiteris

Netherlands, 09 Nov 2025

Markus Dathe

Switzerland, 28 Mar 2025

Big Pharma.

EQUITIES OF THE SAME SECTOR

COSMO Pharmaceuticals N.V.

COSMO Pharmaceuticals N.V. Valor: 32590356

Annual Return

-50%0%+50%

Risk level

110

-0.31%CHF 65.10

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

-0.63%EUR 48.72

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc Valor: 18393960

Annual Return

-50%0%+50%

Risk level

110

1.26%USD 45.00

Globus Medical Inc

Globus Medical Inc Valor: 18329123

Annual Return

-50%0%+50%

Risk level

110

0.55%USD 84.45

HCA Healthcare Inc

HCA Healthcare Inc Valor: 11321027

Annual Return

-50%0%+50%

Risk level

110

-0.13%USD 472.65

AbbVie Inc

AbbVie Inc Valor: 20145667

Annual Return

-50%0%+50%

Risk level

110

0.03%USD 232.36

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

-0.20%USD 5.06

Scilex Holding Company

Scilex Holding Company Valor: 123144552

Annual Return

-50%0%+50%

Risk level

110

-1.01%USD 17.69

Siegfried Holding Ltd

Siegfried Holding Ltd Valor: 1428449

Annual Return

-50%0%+50%

Risk level

110

-1.45%CHF 75.00

Concentra Group Holdings Parent Inc

Concentra Group Holdings Parent Inc Valor: 136105334

Annual Return

-50%0%+50%

Risk level

110

-1.67%USD 19.42

Logos provided by Clearbit

Bristol-Myers Squibb Co

BMY

ISIN null / Valor 914188

Bristol-Myers Squibb Co UMushroom community rating:

Nojus Okleiteris

Markus Dathe

Bristol-Myers Squibb Co
UMushroom community rating: